With the slow fall in the prevalence of smoking, the current population of smokers represent a mix of 'hardened' smokers who have attempted to quit on a number of occasions and others, for example younger smokers.8 Both groups are exposed to increasing community awareness of the harmful effects of smoking and expanding legislative changes to quit.
Identification of readiness to change, level of nicotine dependence and number of previous quit attempts will assist the practitioner in the approach to cessation, especially the use of pharmacotherapy.
Like other pharmacological treatments, combination therapy using drugs with different modes of action has been tried with differing degrees of success.6 Combination therapy can include two alternative forms of nicotine replacement therapy (NRT) or nicotine replacement and buproprion when 'the smoker has not been successful on an adequate trial of one of these therapies'. 1Most formulations of NRT provide doses of nicotine that are below that achieved by smoking.1 Combination NRT includes a formulation that provides basal levels of nicotine (for example nicotine patch) with 'top up' doses when withdrawal and craving are more likely to be a problem, for example first thing in the morning. Top up doses can be provided by a nicotine inhaler, lozenge or gum. Combination therapies should be considered in smokers who have failed despite behavioural intervention and a reasonable trial of a single formulation.
* A summary copy of the time-tiered 5As approach to smoking cessation can be found on the Cancer Council SA website www.cancersa.org.au/i-cms_file?page=544/GPdeskprompt.pdf[cited 2005 May 10]
Conflict of interest: none declared